Utilization of ultrasonic-assisted RESOLV (US-RESOLV) with polymeric stabilizers for production of Amiodarone hydrochloride (cas 19774-82-4) nanoparticles: Optimization of the process parameters
-
Add time:09/03/2019 Source:sciencedirect.com
In this work, for the first time, RESS, RESOLV, and ultrasonic-assisted RESOLV methods were applied to produce Amiodarone hydrochloride (cas 19774-82-4) (AMH) drug nanoparticles. Design of experiments was accomplished by Taguchi method (robust design) to obtain optimized process conditions. Water-soluble polymers, viz. polyvinylpyrrolidone (PVP) and hydroxypropyl methylcellulose (HPMC), were used to stabilize and control the size of the AMH nanoparticles. The results illustrated that the ultrasonic-assisted RESOLV (US-RESOLV) method outperforms conventional methods such as RESS and RESOLV. In order to characterize unprocessed and processed AMH particles, FTIR, DLS, FESEM, XRD, DSC and dissolution rate analyses were employed. DSC studies confirmed lower crystallinity of the AMH produced by US-RESOLV, as compared to original AMH. The US-RESOLV method could provide quasi-spherical particles of significantly smaller mean size (<50 nm) than unprocessed AMH particles (75.4 μm, on average). Moreover, the small particle size, the presence of polymers and ultrasonic waves increased the dissolution rate of the AMH in aqueous solutions by up to 13.2 folds. The combination of ultrasonication with RESOLV technique provided a method of large potentials for producing AMH nanoparticles.
We also recommend Trading Suppliers and Manufacturers of Amiodarone hydrochloride (cas 19774-82-4). Pls Click Website Link as below: cas 19774-82-4 suppliers
Prev:Solubility of an antiarrhythmic drug (Amiodarone hydrochloride (cas 19774-82-4)) in supercritical carbon dioxide: Experimental and modeling
Next:Solubility of Amiodarone hydrochloride (cas 19774-82-4) in aqueous co-solvent mixtures revisited: IBKI preferential solvation analysis) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Case report – Special issue: Panvascular medicine“Blue-grey syndrome” – A rare adverse effect of amiodarone09/09/2019
- Short communicationQuality by design (QbD) based development and validation of an HPLC method for Amiodarone hydrochloride (cas 19774-82-4) and its impurities in the drug substance09/08/2019
- Amiodarone induces cell proliferation and myofibroblast differentiation via ERK1/2 and p38 MAPK signaling in fibroblasts09/07/2019
- Original articleStability study of Amiodarone hydrochloride (cas 19774-82-4) in capsules for paediatric patients using a high-performance liquid chromatography methodÉtude de stabilité des gélules de chlorhydrate d’amiodarone à usage pédiatrique par chromatographie liquide à haute performance09/06/2019
- Original articleOptimized and validated spectrophotometric methods for the determination of Amiodarone hydrochloride (cas 19774-82-4) in commercial dosage forms using N-bromosuccinimide and bromothymol blue09/05/2019
- Solubility of Amiodarone hydrochloride (cas 19774-82-4) in aqueous co-solvent mixtures revisited: IBKI preferential solvation analysis09/04/2019
- Solubility of an antiarrhythmic drug (Amiodarone hydrochloride (cas 19774-82-4)) in supercritical carbon dioxide: Experimental and modeling09/02/2019
-
Health and Chemical more >